Recovery from experimental Parkinsonism by Semaphorin-guided axonal growth of grafted dopamine neurons

Molecular Therapy

Volumn 21, Issue 8, 2013, Pages 1579-1591

  Díaz Martínez, N Emmanuel ^a   Tamariz, Elisa ^b,c   Díaz, N Fabián ^a,d   García Peña, Claudia M ^b   Varela Echavarría, Alfredo ^b   Velasco, Iván ^a  

^a INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

^b INSTITUTO DE NEUROBIOLOGÍA   (Mexico)

^c UNIVERSIDAD VERACRUZANA   (Mexico)

^d INSTITUTO NACIONAL DE PERINATOLOGÍA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN ABC LYASE; DOPAMINE; PROTEOCHONDROITIN SULFATE; SEMAPHORIN; SEMAPHORIN 3A; SEMAPHORIN 3C; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL STRAIN HEK293; CELL TRANSPLANTATION; CONTROLLED STUDY; CORPUS STRIATUM; DEPOLARIZATION; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DORSAL STRIATUM; EMBRYONIC STEM CELL; NERVE FIBER GROWTH; NERVE PROJECTION; NONHUMAN; PARKINSONISM; PROTEIN DEGRADATION; RAT; SUBSTANTIA NIGRA; SURVIVAL RATE; SYNAPSE;

ANIMALIA; RATTUS;

ANIMALS; AXONS; CELL DIFFERENTIATION; CELL LINE; CELL- AND TISSUE-BASED THERAPY; CORPUS STRIATUM; DOPAMINERGIC NEURONS; EMBRYONIC STEM CELLS; FEMALE; HEK293 CELLS; HUMANS; MICE; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; ROTAROD PERFORMANCE TEST; SEMAPHORINS; SUBSTANTIA NIGRA; SYNAPTIC TRANSMISSION; TRANSFECTION;

EID: 84881317792     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2013.78     Document Type: Article

References (50)

1. Freed, CR, Greene, PE, Breeze, RE, Tsai, WY, DuMouchel, W, Kao, R et al. (2001). Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 344: 710-719.
2. Olanow, CW, Goetz, CG, Kordower, JH, Stoessl, AJ, Sossi, V, Brin, MF et al. (2003). A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 54: 403-414.
3. Kim, JH, Auerbach, JM, Rodríguez-Gómez, JA, Velasco, I, Gavin, D, Lumelsky, N et al. (2002). Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418: 50-56.
4. Rodríguez-Gómez, JA, Lu, JQ, Velasco, I, Rivera, S, Zoghbi, SS, Liow, JS et al. (2007). Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease. Stem Cells 25: 918-928.
5. Roy, NS, Cleren, C, Singh, SK, Yang, L, Beal, MF and Goldman, SA (2006). Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med 12: 1259-1268.
6. Wernig, M, Zhao, JP, Pruszak, J, Hedlund, E, Fu, D, Soldner, F et al. (2008). Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci USA 105: 5856-5861.
7. Mendez, I, Sadi, D and Hong, M (1996). Reconstruction of the nigrostriatal pathway by simultaneous intrastriatal and intranigral dopaminergic transplants. J Neurosci 16: 7216-7227.
8. Mukhida, K, Baker, KA, Sadi, D and Mendez, I (2001). Enhancement of sensorimotor behavioral recovery in hemiparkinsonian rats with intrastriatal, intranigral, and intrasubthalamic nucleus dopaminergic transplants. J Neurosci 21: 3521-3530.
9. Olsson, M, Nikkhah, G, Bentlage, C and Björklund, A (1995). Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J Neurosci 15(5 Pt 2): 3863-3875.
10. Giger, RJ, Hollis, ER 2nd and Tuszynski, MH (2010). Guidance molecules in axon regeneration. Cold Spring Harb Perspect Biol 2: a001867.
11. Hernández-Montiel, HL, Tamariz, E, Sandoval-Minero, MT and Varela-Echavarría, A (2008). Semaphorins 3A, 3C, and 3F in mesencephalic dopaminergic axon pathfinding. J Comp Neurol 506: 387-397.
12. Kolk, SM, Gunput, RA, Tran, TS, van den Heuvel, DM, Prasad, AA, Hellemons, AJ et al. (2009). Semaphorin 3F is a bifunctional guidance cue for dopaminergic axons and controls their fasciculation, channeling, rostral growth, and intracortical targeting. J Neurosci 29: 12542-12557.
13. Torre, ER, Gutekunst, CA and Gross, RE (2010). Expression by midbrain dopamine neurons of Sema3A and 3F receptors is associated with chemorepulsion in vitro but a mild in vivo phenotype. Mol Cell Neurosci 44: 135-153.
14. Yamauchi, K, Mizushima, S, Tamada, A, Yamamoto, N, Takashima, S and Murakami, F (2009). FGF8 signaling regulates growth of midbrain dopaminergic axons by inducing semaphorin 3F. J Neurosci 29: 4044-4055.
15. Kolodkin, AL, Levengood, DV, Rowe, EG, Tai, YT, Giger, RJ and Ginty, DD (1997). Neuropilin is a semaphorin III receptor. Cell 90: 753-762.
16. Takahashi, T, Fournier, A, Nakamura, F, Wang, LH, Murakami, Y, Kalb, RG et al. (1999). Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors. Cell 99: 59-69.
17. Luo, Y, Raible, D and Raper, JA (1993). Collapsin: a protein in brain that induces the collapse and paralysis of neuronal growth cones. Cell 75: 217-227.
18. Messersmith, EK, Leonardo, ED, Shatz, CJ, Tessier-Lavigne, M, Goodman, CS and Kolodkin, AL (1995). Semaphorin III can function as a selective chemorepellent to pattern sensory projections in the spinal cord. Neuron 14: 949-959.
19. Behar, O, Golden, JA, Mashimo, H, Schoen, FJ and Fishman, MC (1996). Semaphorin III is needed for normal patterning and growth of nerves, bones and heart. Nature 383: 525-528.
20. Bagnard, D, Lohrum, M, Uziel, D, Püschel, AW and Bolz, J (1998). Semaphorins act as attractive and repulsive guidance signals during the development of cortical projections. Development 125: 5043-5053.
21. Polleux, F, Morrow, T and Ghosh, A (2000). Semaphorin 3A is a chemoattractant for cortical apical dendrites. Nature 404: 567-573.
22. Wu, KY, Hengst, U, Cox, LJ, Macosko, EZ, Jeromin, A, Urquhart, ER et al. (2005). Local translation of RhoA regulates growth cone collapse. Nature 436: 1020-1024.
23. Niquille, M, Garel, S, Mann, F, Hornung, JP, Otsmane, B, Chevalley, S et al. (2009). Transient neuronal populations are required to guide callosal axons: a role for semaphorin 3C. PLoS Biol 7: e1000230.
24. Tamariz, E, Díaz-Martínez, NE, Díaz, NF, García-Peña, CM, Velasco, I and Varela-Echavarría, A (2010). Axon responses of embryonic stem cellderived dopaminergic neurons to semaphorins 3A and 3C. J Neurosci Res 88: 971-980.
25. Díaz, NF, Díaz-Martínez, NE, Camacho-Arroyo, I and Velasco, I (2009). Estradiol promotes proliferation of dopaminergic precursors resulting in a higher proportion of dopamine neurons derived from mouse embryonic stem cells. Int J Dev Neurosci 27: 493-500.
26. Alilain, WJ, Horn, KP, Hu, H, Dick, TE and Silver, J (2011). Functional regeneration of respiratory pathways after spinal cord injury. Nature 475: 196-200.
27. Bradbury, EJ, Moon, LD, Popat, RJ, King, VR, Bennett, GS, Patel, PN et al. (2002). Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416: 636-640.
28. Minor, KH, Bournat, JC, Toscano, N, Giger, RJ and Davies, SJ (2011). Decorin, erythroblastic leukaemia viral oncogene homologue B4 and signal transducer and activator of transcription 3 regulation of semaphorin 3A in central nervous system scar tissue. Brain 134(Pt 4): 1140-1155.
29. Rubio, SE, Martínez, A, Chauvet, S, Mann, F, Soriano, E and Pascual, M (2011). Semaphorin 3C is not required for the establishment and target specificity of the GABAergic septohippocampal pathway in vitro. Eur J Neurosci 34: 1923-1933.
30. Schmued, LC and Fallon, JH (1986). Fluoro-Gold: a new fluorescent retrograde axonal tracer with numerous unique properties. Brain Res 377: 147-154.
31. Mendez, I, Baker, KA and Hong, M (2000). Simultaneous intrastriatal and intranigral grafting (double grafts) in the rat model of Parkinson's disease. Brain Res Brain Res Rev 32: 328-339.
32. Bukhatwa, S, Iravani, MM, Zeng, BY, Cooper, JD, Rose, S and Jenner, P (2009). An immunohistochemical and stereological analysis of PSI-induced nigral neuronal degeneration in the rat. J Neurochem 109: 52-59.
33. Courtès, S, Vernerey, J, Pujadas, L, Magalon, K, Cremer, H, Soriano, E et al. (2011). Reelin controls progenitor cell migration in the healthy and pathological adult mouse brain. PLoS ONE 6: e20430.
34. Kantor, DB, Chivatakarn, O, Peer, KL, Oster, SF, Inatani, M, Hansen, MJ et al. (2004). Semaphorin 5A is a bifunctional axon guidance cue regulated by heparan and chondroitin sulfate proteoglycans. Neuron 44: 961-975.
35. Piaton, G, Aigrot, MS, Williams, A, Moyon, S, Tepavcevic, V, Moutkine, I et al. (2011). Class 3 semaphorins influence oligodendrocyte precursor recruitment and remyelination in adult central nervous system. Brain 134(Pt 4): 1156-1167.
36. Varela-Echavarría, A, Tucker, A, Püschel, AW and Guthrie, S (1997). Motor axon subpopulations respond differentially to the chemorepellents netrin-1 and semaphorin D. Neuron 18: 193-207.
37. Kaneko, S, Iwanami, A, Nakamura, M, Kishino, A, Kikuchi, K, Shibata, S et al. (2006). A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord. Nat Med 12: 1380-1389.
38. Van Kampen, JM and Eckman, CB (2006). Dopamine D3 receptor agonist delivery to a model of Parkinson's disease restores the nigrostriatal pathway and improves locomotor behavior. J Neurosci 26: 7272-7280.
39. Gaillard, A, Decressac, M, Frappé, I, Fernagut, PO, Prestoz, L, Besnard, S et al. (2009). Anatomical and functional reconstruction of the nigrostriatal pathway by intranigral transplants. Neurobiol Dis 35: 477-488.
40. Thompson, LH, Grealish, S, Kirik, D and Björklund, A (2009). Reconstruction of the nigrostriatal dopamine pathway in the adult mouse brain. Eur J Neurosci 30: 625-638.
41. Zhao, S, Maxwell, S, Jimenez-Beristain, A, Vives, J, Kuehner, E, Zhao, J et al. (2004). Generation of embryonic stem cells and transgenic mice expressing green fluorescence protein in midbrain dopaminergic neurons. Eur J Neurosci 19: 1133-1140.
42. Hedlund, E, Pruszak, J, Lardaro, T, Ludwig, W, Viñuela, A, Kim, KS et al. (2008). Embryonic stem cell-derived Pitx3-enhanced green fluorescent protein midbrain dopamine neurons survive enrichment by fluorescence-activated cell sorting and function in an animal model of Parkinson's disease. Stem Cells 26: 1526-1536.
43. Grealish, S, Jönsson, ME, Li, M, Kirik, D, Björklund, A and Thompson, LH (2010). The A9 dopamine neuron component in grafts of ventral mesencephalon is an important determinant for recovery of motor function in a rat model of Parkinson's disease. Brain 133(Pt 2): 482-495.
44. O'Keeffe, FE, Scott, SA, Tyers, P, O'Keeffe, GW, Dalley, JW, Zufferey, R et al. (2008). Induction of A9 dopaminergic neurons from neural stem cells improves motor function in an animal model of Parkinson's disease. Brain 131(Pt 3): 630-641.
45. Studer, L, Tabar, V and McKay, RD (1998). Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat Neurosci 1: 290-295.
46. Lee, SH, Lumelsky, N, Studer, L, Auerbach, JM and McKay, RD (2000). Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol 18: 675-679.
47. Liu, CQ, Hu, DN, Liu, FX, Chen, Z and Luo, JH (2008). Apomorphine-induced turning behavior in 6-hydroxydopamine lesioned rats is increased by histidine and decreased by histidine decarboxylase, histamine H1 and H2 receptor antagonists, and an H3 receptor agonist. Pharmacol Biochem Behav 90: 325-330.
48. Schallert, T, Fleming, SM, Leasure, JL, Tillerson, JL and Bland, ST (2000). CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39: 777-787.
49. Guzmán-Ramos, K, Osorio-Gómez, D, Moreno-Castilla, P and Bermúdez-Rattoni, F (2010). Off-line concomitant release of dopamine and glutamate involvement in taste memory consolidation. J Neurochem 114: 226-236.
50. Coggeshall, RE and Lekan, HA (1996). Methods for determining numbers of cells and synapses: a case for more uniform standards of review. J Comp Neurol 364: 6-15.